ARCHIVES

ODAC Rejects Amsacrine NDA, Renews Idarubicin

This article is from The Cancer Letter archive.

Vol. 16 No. 35 | September 14, 1990

Download PDF Visit The Full Archive

Related Articles

NCI May Seek Cuts In R01s, P01s If Congress Approves Rescission

January 30, 1981

Senate Subcommittee Votes $970 Million for NCI In FY 1980; Magnuson Cancer Support Holds Firm

June 23, 1978

AACR, ASCO Members Concerned Over Ethics, Social Issues, And What To Do About Them

May 16, 1975

ACS Unveils Plan For Combating Tobacco Marketing

May 18, 1990

CTEP Drafts FDA Approval Guidelines

March 4, 1988

Health Organizations: ACS Statement Supports funding of Research On Human Stem cells

December 17, 1999